إعلان
إعلان
PLX
Protalix BioTherapeutics, Inc. Common Stock
1.78
USDبرعاية
+0.01
+0.73%
٠٧ يناير, ١٦:٠٠ UTC -5
مغلق
بعد الإغلاق
1.75
-0.03
-1.57%
تقارير أرباح PLX
النسبة الإيجابية المفاجئة
PLX تفوق 19 من 38 آخر التقديرات.
50%
التقرير التالي
بيانات التقرير القادم
١٦ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$16.97M
/$0.03
التغير الضمني من Q3 25 (Revenue/ EPS)
-4.93%
/--
التغير الضمني من Q4 24 (Revenue/ EPS)
-6.84%
/-66.67%
Protalix BioTherapeutics, Inc. Common Stock earnings per share and revenue
On ١٣ نوفمبر ٢٠٢٥, PLX reported earnings of 0.03 USD per share (EPS) for Q3 25, missing the estimate of 0.05 USD, resulting in a -46.04% surprise. Revenue reached 17.85 مليون, compared to an expected 18.04 مليون, with a -1.07% difference. The market reacted with a -9.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 المحللين forecast an EPS of 0.03 USD, with revenue projected to reach 16.97 مليون USD, implying an زيادة of 0.00% EPS, and نقصان of -4.93% in Revenue from the last quarter.
الأسئلة الشائعة
What were Protalix BioTherapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Protalix BioTherapeutics, Inc. Common Stock reported EPS of $0.03, missing estimates by -46.04%, and revenue of $17.85M, -1.07% below expectations.
How did the market react to Protalix BioTherapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -9.81%, changed from $2.14 before the earnings release to $1.93 the day after.
When is Protalix BioTherapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ١٦ مارس ٢٠٢٦.
What are the forecasts for Protalix BioTherapeutics, Inc. Common Stock's next earnings report?
Based on 3
المحللين, Protalix BioTherapeutics, Inc. Common Stock is expected to report EPS of $0.03 and revenue of $16.97M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان